NetScientific PLC (LON:NSCI), the healthcare investment group, said the chief scientific officer of one of its investee companies has won industry recognition.
Vortex Biosciences' Elodie Sollier-Christen received the 2017 Society award for Laboratory Automation and Screening Innovation.
Her presentation to the judges was entitled Vortex Technology for fast and label-free isolation of circulating tumour cells from blood samples.
In it she discussed a breakthrough by Vortex in the isolation of circulating tumour cells from blood samples.
NetScientific chief executive François Martelet said: "We wish to extend our warm congratulations to Elodie on her receipt of this prestigious award.
“We view this prize as a recognition of her extraordinary work on the cutting edge technology utilised by Vortex on the design of the VTX-1 liquid biopsy system.
“We believe that this technology has great potential to significantly impact laboratory automation and screening and we are delighted to see it receive due recognition."